Artrya Limited announced the appointment of Dr. Jacque Sokolov to the Board as a non-executive director effective immediately. Dr. Sokolov is Chairman and Chief Executive Officer of SSB Solutions Inc. His company has worked with more than 100 healthcare organizations across multiple US healthcare sectors to develop physician-driven, value-focused solutions in rapidly evolving markets. Dr. Sokolov currently serves on multiple public, private and not-for-profit healthcare boards.

He is especially focused on leading technology involving advanced digital health companies such as GlobalMed and next-generation genetic-based companies such as Calviri (mRNA diagnostics/products) and Lucid Diagnostics. Dr. Sokolov received his BA and MD Degrees from the University of Southern California and completed his internal medicine residency at the Mayo Graduate School of Medicine followed by his fellowship in cardiovascular diseases/nuclear cardiology from the University of Texas-Southwestern Medical School. Dr. Sokolov was appointed Artrya Clinical Advisory Board Chair in January 2022 and Chairman and President of Artrya USA Inc. in March 2022.